Related Experiment Video
Updated: Jan 21, 2026

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
5.5K
PlatformTM, a standards-based data custodianship platform for translational medicine research.
Ibrahim Emam1, Vahid Elyasigomari2, Alex Matthews3
1Data Science Institute, Imperial College London, London, UK. i.emam@imperial.ac.uk.
Scientific Data
|August 15, 2019
Summary
Translational medicine (TM) research needs better data management. We developed a lifecycle-based methodology and PlatformTM to manage TM data assets, supporting data reuse and reproducibility.
Area of Science:
- Biomedical Informatics
- Translational Medicine Research
Background:
- Traditional biomedical informatics in translational medicine (TM) focuses on data collection, storage, and analysis, often overlooking data lifecycle management.
- Emerging emphasis on data reuse, long-term preservation, and sharing highlights a gap in infrastructure for managing the TM data lifecycle between collection and analysis.
- Open science initiatives necessitate a data custodianship environment to enhance the management of TM data assets for improved research reproducibility.
Purpose of the Study:
- To address the need for improved data management in translational medicine research.
- To develop a lifecycle-based methodology and a supporting platform for managing TM data assets.
Main Methods:
- Developed a lifecycle-based methodology for metadata management in TM research.
- Established a metadata management framework utilizing community-driven standards for data standardization, consolidation, and integration.
- Created a new platform, PlatformTM, to manage the data lifecycle for translational research assets.
Main Results:
- A novel lifecycle-based methodology for TM data management has been established.
- A metadata management framework aligned with community standards has been created.
- PlatformTM, a dedicated system for managing the TM data lifecycle, has been developed.
Conclusions:
- Effective management of the TM data lifecycle is crucial for supporting data reuse and research reproducibility.
- The developed methodology and PlatformTM provide essential infrastructure for managing TM data assets.
- This work contributes to fostering a culture of open science in translational medicine research.
More Related Videos
Related Concept Videos
Translation
155.7K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.7K
Translation
17.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.6K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Termination of Translation
6.6K
6.6K

